Anti-Cetuximab Rabbit Polyclonal Antibody

The anti-Cetuximab antibody is a monoclonal or polyclonal antibody that specifically recognizes and targets Cetuximab. It is primarily used in scientific research, clinical testing, and drug monitoring. Cetuximab is a chimeric monoclonal antibody drug targeting the Epidermal Growth Factor Receptor (EGFR), widely used in the treatment of various malignant tumors such as colorectal cancer and head and neck squamous cell carcinoma. By binding to specific epitopes of Cetuximab, the Anti-Cetuximab antibody can be employed in experimental techniques like Enzyme-Linked Immunosorbent Assay (ELISA), Western Blot, and Immunohistochemistry (IHC) to quantify Cetuximab concentration in biological samples, analyze its pharmacokinetic properties, or assess the potential development of anti-drug antibodies (ADA) in patients. Furthermore, this antibody aids in researching resistance mechanisms to Cetuximab, such as monitoring changes in the EGFR signaling pathway or the efficiency of drug-receptor binding, thereby providing a critical tool for optimizing targeted therapy regimens.